Current perspectives on the nucleoside/nucleotide components of combination antiretroviral therapy.
Baltimore, MD, USA.
Joel E
JE
Gallant
D000241:Adenosine / Q000031:analogs & derivatives; D019380:Anti-HIV Agents / Q000737:chemistry / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000639:trends*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans
D019380:Anti-HIV Agents; D000241:Adenosine